Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew Rappaport files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David C. Myles - $3.11M in OLMA purchases and sales in the last 12 months
- Shane William Charles Kovacs - $2.98M in OLMA purchases and sales in the last 12 months
- Shawnte Mitchell - $952K in OLMA purchases and sales in the last 12 months
- Cyrus Harmon - $662K in OLMA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew Rappaport?
Andrew Rappaport is a corporate insider of Olema Pharmaceuticals, Inc. (OLMA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Andrew Rappaport last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 3 filings going back to 2025.
